Indivior Pharmaceuticals, Inc. Common Stock (NASDAQ: INDV) last traded at $35.83, up 1.07% on the session. The quote above updates while this page is open; the figures below are drawn from Indivior Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Indivior Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker INDV. Its market capitalisation is $4.23 billion.
Valuation measures for Indivior Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.23B |
|---|---|
| Enterprise value | $5.45B |
| P/E ratio | 12.84 |
| Price / sales | 3.18 |
| Beta | 0.46 |
Trailing-twelve-month figures tagged in Indivior Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.33B |
|---|---|
| Net income (TTM) | $356.00M |
| EPS (TTM) | $2.79 |
| Gross margin | 82.19% |
| Operating margin | 31.63% |
| Cash | $222.00M |
Range and volume for INDV over the past 52 weeks.
| 52-week high | $42.81 |
|---|---|
| 52-week low | $23.55 |
| Volume | 4.80M |
| Average volume | 2.12M |
| Previous close | $35.45 |
Invest a chosen dollar amount in Indivior Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell INDV.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.